RPHM insider filings
Reneo Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-09-26. Screen RPHM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for RPHM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Reneo Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-09-26 | 4 | Leonard Braden Michael — 10% owner | Purchase (P): 29,600 @ $1.41 · Purchase (P): 68,746 @ $1.50 | EDGAR |
| 2024-09-19 | 4 | Leonard Braden Michael — 10% owner | Purchase (P): 55,300 @ $1.36 · Purchase (P): 806 @ $1.40 | EDGAR |
| 2024-09-16 | 4 | Leonard Braden Michael — 10% owner | Purchase (P): 36,176 @ $1.40 · Purchase (P): 150,000 @ $1.31 · Purchase (P): 172,747 @ $1.37 | EDGAR |
| 2024-08-14 | 4 | Leonard Braden Michael — 10% owner | Purchase (P): 171,339 @ $1.39 · Purchase (P): 100,487 @ $1.41 | EDGAR |
| 2024-05-16 | 4 | Leonard Braden Michael — 10% owner | Purchase (P): 79,281 @ $1.56 · Purchase (P): 335,000 @ $1.54 | EDGAR |
| 2023-08-29 | 4 | Hall Ashley — Chief Development Officer | Option exercise (M): 15,625 @ $1.80 · Sale (S): 15,625 @ $6.28 · Option exercise (M): 15,625 (derivative) @ $0 | EDGAR |
| 2023-07-27 | 4 | GREY MICHAEL G — Executive Chairman, Director | Gift (G): 50,000 @ $0 | EDGAR |
| 2023-06-23 | 4 | Novo Holdings A/S — 10% owner | Sale (S): 100,000 @ $7.10 | EDGAR |
| 2023-06-08 | 4 | Blunt Roshawn A. — Director | Grant/award (A): 14,815 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Muralidhar Bali — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | O'Donnell Niall — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Seltzer Stacey Denenberg — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Dube Eric M — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Hoelscher Paul W. — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Mathers Edward T — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | GREY MICHAEL G — Executive Chairman, Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-05-10 | 4 | O'Donnell Niall — Director | Purchase (P): 125,000 @ $8 | EDGAR |
| 2022-12-13 | 4 | Lam Jennifer — VP of Finance & Administration | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Hall Ashley — Chief Development Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | FLESHER GREGORY J. — President and CEO, Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Cruse Michael — Chief Operating Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Dorenbaum Alejandro — Chief Medical Officer | Gift (G): 22,348 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-09-02 | 4 | Cruse Michael — Chief Operating Officer | Purchase (P): 7,500 @ $3.39 | EDGAR |
| 2022-09-02 | 4 | GREY MICHAEL G — Executive Chairman, Director | Option exercise (M): 50,000 @ $1.97 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2022-08-31 | 4 | Cruse Michael — Chief Operating Officer | Purchase (P): 83 @ $3.24 · Purchase (P): 1,140 @ $3.24 · Purchase (P): 975 @ $3.16 · Purchase (P): 1,845 @ $3.19 · Purchase (P): 3,212 @ $3.21 | EDGAR |
| 2022-08-02 | 4 | Blunt Roshawn A. — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Dube Eric M — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Muralidhar Bali — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | O'Donnell Niall — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Seltzer Stacey Denenberg — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Hoelscher Paul W. — Director | Grant/award (A): 6,376 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Mathers Edward T — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | GREY MICHAEL G — Executive Chairman, Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | Cruse Michael — Chief Operating Officer | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-01-24 | 4 | Hoelscher Paul W. — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Jindal Vineet R. — Chief Financial Officer | Grant/award (A): 30,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | FLESHER GREGORY J. — President and CEO, Director | Grant/award (A): 100,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Cruse Michael — Senior VP-Corporate Operations | Grant/award (A): 25,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Dorenbaum Alejandro — Chief Medical Officer | Grant/award (A): 30,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-11-15 | 4 | Hall Ashley — Chief Development Officer | Grant/award (A): 30,000 @ $0 · Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2021-08-26 | 4 | Jindal Vineet R. — Chief Financial Officer | Purchase (P): 5,000 @ $7.44 | EDGAR |
| 2021-08-26 | 4 | FLESHER GREGORY J. — President and CEO, Director | Purchase (P): 8,000 @ $8 | EDGAR |
| 2021-08-26 | 4 | Cruse Michael — Senior VP-Corporate Operations | Purchase (P): 2,500 @ $7.45 | EDGAR |
| 2021-07-15 | 4 | Muralidhar Bali — Director | Purchase (P): 111,736 @ $8.50 | EDGAR |
| 2021-07-15 | 4 | Johnson Wendy S. — Chief Development Officer | Sale (S): 111,736 @ $8.50 | EDGAR |
| 2021-07-09 | 4 | Johnson Wendy S. — Chief Development Officer | Option exercise (M): 111,736 @ $1.97 · Option exercise (M): 111,736 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Muralidhar Bali — Director | Purchase (P): 20,710 @ $9.28 | EDGAR |
| 2021-06-23 | 4 | Muralidhar Bali — Director | Purchase (P): 32,659 @ $9.03 · Purchase (P): 14,615 @ $8.72 | EDGAR |
| 2021-06-10 | 4 | Muralidhar Bali — Director | Purchase (P): 16,605 @ $9.50 | EDGAR |
| 2021-06-07 | 4 | Muralidhar Bali — Director | Purchase (P): 12,100 @ $9.25 · Purchase (P): 257 @ $9.42 | EDGAR |
Recent 8-K events — Reneo Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RPHM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs